BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25910708)

  • 1. Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines.
    Mikulenkova E; Neradil J; Zitterbart K; Sterba J; Veselska R
    Tumour Biol; 2015 Sep; 36(10):7483-91. PubMed ID: 25910708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
    Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
    Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular distribution of the ΔNp73 protein isoform in medulloblastoma cells: a study with newly generated rabbit polyclonal antibodies.
    Veselska R; Neradil J; Nekulova M; Dobrucka L; Vojtesek B; Sterba J; Zitterbart K
    Histol Histopathol; 2013 Jul; 28(7):913-24. PubMed ID: 23338942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the intracellular localization of p73 N-terminal protein isoforms TAp73 and ∆Np73 in medulloblastoma cell lines.
    Nekulová M; Zitterbart K; Sterba J; Veselská R
    J Mol Histol; 2010 Oct; 41(4-5):267-75. PubMed ID: 20803057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
    Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
    Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEC1 coordinates with HDAC8 to differentially regulate TAp73 and ΔNp73 expression.
    Qian Y; Zhang J; Jung YS; Chen X
    PLoS One; 2014; 9(1):e84015. PubMed ID: 24404147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells.
    Simões-Wüst AP; Sigrist B; Belyanskaya L; Hopkins Donaldson S; Stahel RA; Zangemeister-Wittke U
    J Neurooncol; 2005 Mar; 72(1):29-34. PubMed ID: 15803372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival.
    Zitterbart K; Zavrelova I; Kadlecova J; Spesna R; Kratochvilova A; Pavelka Z; Sterba J
    Acta Neuropathol; 2007 Dec; 114(6):641-50. PubMed ID: 17912537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
    Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
    J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative expression of TAp73 and ΔNp73 isoforms.
    Conforti F; Yang AL; Agostini M; Rufini A; Tucci P; Nicklison-Chirou MV; Grespi F; Velletri T; Knight RA; Melino G; Sayan BS
    Aging (Albany NY); 2012 Mar; 4(3):202-5. PubMed ID: 22388545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
    Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
    J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.
    Sayan BS; Yang AL; Conforti F; Tucci P; Piro MC; Browne GJ; Agostini M; Bernardini S; Knight RA; Mak TW; Melino G
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12877-82. PubMed ID: 20615966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.
    Di Vinci A; Sessa F; Casciano I; Banelli B; Franzi F; Brigati C; Allemanni G; Russo P; Dominioni L; Romani M
    Int J Oncol; 2009 Feb; 34(2):449-56. PubMed ID: 19148480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.
    Vilgelm AE; Hong SM; Washington MK; Wei J; Chen H; El-Rifai W; Zaika A
    Oncogene; 2010 Oct; 29(43):5861-8. PubMed ID: 20676143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
    Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
    J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway.
    Wilhelm MT; Rufini A; Wetzel MK; Tsuchihara K; Inoue S; Tomasini R; Itie-Youten A; Wakeham A; Arsenian-Henriksson M; Melino G; Kaplan DR; Miller FD; Mak TW
    Genes Dev; 2010 Mar; 24(6):549-60. PubMed ID: 20194434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer.
    Lai J; Nie W; Zhang W; Wang Y; Xie R; Wang Y; Gu J; Xu J; Song W; Yang F; Huang G; Cao P; Guan X
    Oncotarget; 2014 Aug; 5(16):6909-22. PubMed ID: 25071010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
    Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
    Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.